Francois Binette

Francois Binette is the Founder and CEO of Tidewave Bio, an oncology-focused biotechnology company developing a next-generation, allogeneic, point-of-care–personalized immunotherapy platform for solid tumors. Francois brings over 30 years of experience across biologics, cell and gene therapy, medical devices, and advanced manufacturing, with senior leadership roles spanning large pharma, medtech, and venture-backed biotech. His career includes executive and strategic roles at companies such as Johnson & Johnson, Medtronic, Genzyme, Lineage Cell Therapeutics, and Renovaro Biosciences, where he has led product development, corporate strategy, partnerships, and capital formation across multiple therapeutic areas. Francois has extensive experience navigating international regulatory pathways, scaling complex technologies, and building integrated solutions that align clinical innovation with real-world healthcare and economic constraints. At Tidewave Bio, Francois is focused on addressing the core barriers that have limited the success of advanced therapies in solid tumors—scalability, cost, pharmacology, and patient access—by integrating precision diagnostics, procedural innovation, and immunotherapy into a unified care-continuum platform.